Mast Therapeutics, Inc. (MSTX)

[SC 388]

Ultimate Goal of Adventrx:

This is my first post here, and want to share this with all
sincere investors in ANX.

I found this one while trying to research "nano-emulsion technology" which was developed by
Dr. Andrew Chen, Ph.D., the co-founder of SD Pharma that was bought out by ANX in April 2006.
I really wanted to know if ANX has a "patent" on this nano-emulsion technology. I didn't find any definite
answer. It seems like ANX owns the "worldwide intellectual property rights" to some drugs acquired
from SD Pharma. It is patentable, but ANX doesn't own any patent.

The reason why I am sending you this is to let you know about a couple of very fascinating facts in it.

1. Brian Culley's Past Experience:
"Mr. Culley has over 15 years of experience in the biotechnology industry, including deal structure
and negotiation, licensing, due diligence, market and competitive research, and venture funding."

2. TWST: How would you like to see the company evolve over the next couple of years?
Mr. Culley: We’re strongly committed to creating value for ADVENTRX stockholders. That might mean
we will be acquired or will remain as an independent business, and we will make those determinations
as we grow, but we will always make the decision that we believe maximizes our value on a risk-adjusted basis.
We know that focusing on products that are desired by patients and doctors will naturally create a
high-value company, so we are open-minded as to the ultimate outcome. We have and will continue to entertain
credible discussions concerning partnering and acquisition, but in the meantime we will move forward on
the regulatory and commercial plan I’ve described and build the business with both long- and short-term value in mind.

I think we have the answer!!! I'm curious about how you will interpret his response. Here is my interpretation.
This interview was done on Oct. 19, 2009. He made a "No Comment" comment during Jan. 2010 conference
in S.F. I'm sure that THE "ULTIMATE" GOAL OF BRIAN CULLEY AND ANX IS TO SELL THE COMPANY AT THE MAXIMUM
VALUE. That's why ANX brought in Brian Culley who has 15 year experience in "deal structure and negotiation."
And, look at all the recent developments: Icahn's recent moves, Dr. Kostas on ANX board, Dr. Rowinsky on both ANX
and Biogen board, Dr. Kostas & Dr. Rowinsky's prior involvement with ImClone, constant attempt to push down the
stock price, etc. His response to TWST makes me believe that they have had some buyout talks. Doesn't it all make sense?

I just hope that the buyout hope becomes a reality soon.
Good luck to all "sincere" investors!

What are your thoughts on this, Zigzagman?
I always appreciate your insightful posts here.

Here is the link:
http://www.adventrx.com/assets/pdfs/ANX-TWST-Oct09-FINAL.pdf